Shanghai Haohai Biological To Stage $305 Million IPO In Hong Kong

Shanghai Haohai Biological Technology, a company that makes medical products from absorbable biomedical materials, announced plans to raise as much as $305 million in an IPO on the Hong Kong Stock Exchange. The company will use 25% of the proceeds to update its production facilities and another 25% for acquisitions of other biomedical material companies. The company has a portfolio of 14 biomedical...